Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03458247
Title Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer (OPTIMABI)
Acronym OPTIMABI
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Department of Medical Oncology, Cochin Hospital Paris 75014 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field